Successful pain control by enzyme replacement therapy continued after living donor renal transplantation for end-stage renal failure in a patient with Fabry disease: A case report

A 31-year-old man with Fabry disease was treated with hemodialysis because he had developed end-stage renal failure.However, hemodialysis treatment could not be continued due to uncontrolled systemic pain, and subsequently the patient received a renal transplant from his biological father who was not a carrier of Fabry disease.Good renal graft function and better pain control compared with before surgery were achieved, and the patient returned to society.Control of systemic pain, which is a primary symptom in patients with Fabry disease who develop renal failure can be improved.